Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Tops Revenue Estimates

Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to loss of $0.69 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 27.85%. A quarter ago, it was expected that this company would post a loss of $0.72 per share when it actually produced a loss of $0.34, delivering a surprise of 52.78%.Over the last four quarters, the company ha ...